Health
Author`s name Lisa Karpova

Brazil and Cuba Become an Example of Cooperation in Vaccines

Brazil and Cuba Become an Example of Cooperation in Vaccines

Not in Brazilian ports (except the land), but the news is already circulating around the world of a study that researchers from five developing countries, in collaboration with the McLaughlin-Rotman Centre for Global Health of Canada (MRC) published today in the journal Nature Biotechnology, puts Brazil and Cuba as models in manufacturing low-cost drugs to poor people.

The work, the first study in large-scale "South-South" cooperation in the field of biotechnology related to health, highlights the cooperation between the BioManguinhos - a company linked to the Oswaldo Cruz Foundation in Rio and Instituto Finlay, Cuba, as a model able to save thousands of human lives. I will transcribe what Halla Torsteinsdóttir, Director of the study and member of the McLaughlin-Rotman Centre, the agency EFE said because it is very nice, we like to start the day with her:

-In 2007, there was an outbreak of meningitis in the "meningitis belt," a band of sub-Saharan countries stretching from Senegal to Ethiopia. The World Health Organization (WHO) began seeking a company that could produce an appropriate vaccine for the epidemic."

Thousands died and tens of thousands have been affected by the disease, which is the result of inflammation of a thin layer that surrounds the brain and spinal cord resulting from a bacterial infection. WHO determined that collaboration between the Finlay Institute, which has extensive experience in the fight against meningitis in Haiti, and the company Bio-Mangunhos, was the best option to produce a vaccine against this type of meningitis.

- Vaccines against meningitis created by large pharmaceutical companies were more complex and expensive than that derived from Brazil or Cuba, because they are designed to combat several types of meningitis. And did not cover the cepa (a specific bacteria) in Africa. The vaccine produced by Western companies is $80 per unit, while the price of those produced by the cooperation between Cuba and Brazil was less than $1."

According to research, Brazil, China, Cuba, Egypt, India and South Africa have launched about 280 South-South partnerships for the development of medicines and treatments. The country that has the most initiatives is Brazil, with 64, followed by South Africa with 61 and Portugal with 54. Cuba has 34, seven more than China.

Translated from the Portuguese version by:

Lisa KARPOVA

PRAVDA.Ru

Comments
Kim-Trump Summit: A step in the right direction?
Russia sends assault ships to counter US aircraft carriers in the Mediterranean Sea
Eighteen tons of gold leave USA in 2018
What do foreign fans say about Russia during 2018 FIFA World Cup?
Trump-Kim honeymoon in Singapore may open McDonald's in Pyongyang
Euro-Islam: New religion to break migrants in EU
Euro-Islam: New religion to break migrants in EU
Mysteries of history: Greek fire, Damascus steel and beam weapon
Mysteries of history: Greek fire, Damascus steel and beam weapon
Careful with Iceland!!
Taxi cab rams into pedestrians in Moscow
Experts name reasons that led to the crash of the An-148 near Moscow
"Lend a Hand" - Kit to promote the inclusion of migrant and refugee children in schools
Austria shows its 'ugly face' to Islam?
The West persistently pesters former USSR with regime changes and revolutions
Trump officially starts trade war with China
Bombing of Yugoslavia killed Russia's relations with the West
Putin's interview for Austrian television: Tough answers to most provocative questions
The West persistently pesters former USSR with regime changes and revolutions
Most Russians treat Day of Russia as unimportant holiday
Yemen: 200,000 cholera cases